Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NNNN

Anbio Biotechnology

CIK 0001982708 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$6.81
↓ 0.52 (-7.09%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$298.90M
P/E Ratio
46.68
EPS
0.15
Dividend Yield
Not covered
52W Position
0%
Beta
0.17

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
9.91
P/S
34.57
EV/Revenue
33.67
ROE
21.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 0%
$6.61$54.50

Latest Financials

2025-12-31 FY
Revenue
$8.65M
Net Income
$6.40M
Total Assets
$30.24M
Free Cash Flow
–

Recent news